Sign in
Taking peopleNo phase

Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton Syndrome

Key facts

Who runs it
Assistance Publique - Hôpitaux de Paris
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
30 people, planned
Started
26 May 2026
Expected to end
May 2028
Type of study
Observational, 2 groups
Treatments tested
  • Superficial skin swabs
  • Stool samples
  • Saliva samples
  • Blood samples
  • Data-Collection
Record updated
30 June 2026

Who can take part

Age
10 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Group A:
  • Children aged 10 years and older and adults with confirmed Netherton syndrome diagnosed at age 10 years or older (clinical and histological and/or molecular)
  • Patients and legal guardians informed about the study and not opposed to participation in the study; Group B:
  • Children aged 10 years and older and adults with no skin barrier impairment, dermatosis, inflammatory disease, or autoimmune disease
  • Subjects and legal guardians informed about the study and who do not object to participation in the study

Who cannot take part

  • General or local antibiotic therapy within the month preceding the consultation
  • Refusal by parents/guardians, children, adolescents, or adults

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

It is proposed to conduct an exploratory study to analyze the skin, intestinal, and salivary microbiome, as well as the skin mycobiome and virome, of patients (adolescents and young adults) with Netherton syndrome, a condition characterized by an impaired skin barrier that most likely promotes the development of allergic manifestations.

Read full original descriptionShow less

The study will be conducted on patients with Netherton syndrome and control subjects in order to investigate possible correlation factors between the three microbiomes and identify which ones.

The 2 groups in the trial

  • Patients with Netherton syndrome

    15 children, adolescents, and young adults with Netherton syndrome

    Treatment: Superficial skin swabs, Stool samples, Saliva samples, Blood samples, and Data-Collection

  • Control subjects

    15 control subjects of the same age group and gender, treated at the service but with no dermatosis or inflammatory and/or autoimmune diseases.

    Treatment: Superficial skin swabs, Stool samples, Saliva samples, Blood samples, and Data-Collection

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
30 June 2026